BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32226544)

  • 1. Nrf2 and HIF1α converge to arsenic-induced metabolic reprogramming and the formation of the cancer stem-like cells.
    Bi Z; Zhang Q; Fu Y; Wadgaonkar P; Zhang W; Almutairy B; Xu L; Rice M; Qiu Y; Thakur C; Chen F
    Theranostics; 2020; 10(9):4134-4149. PubMed ID: 32226544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming.
    Zhang HS; Du GY; Zhang ZG; Zhou Z; Sun HL; Yu XY; Shi YT; Xiong DN; Li H; Huang YH
    Int J Biochem Cell Biol; 2018 Feb; 95():85-92. PubMed ID: 29275212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Inorganic Arsenic on Human Prostate Stem-Progenitor Cell Transformation, Autophagic Flux Blockade, and NRF2 Pathway Activation.
    Xie L; Hu WY; Hu DP; Shi G; Li Y; Yang J; Prins GS
    Environ Health Perspect; 2020 Jun; 128(6):67008. PubMed ID: 32525701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1α signaling in human epithelial ovarian cancer.
    Zhang Z; Wang Q; Ma J; Yi X; Zhu Y; Xi X; Feng Y; Jin Z
    Oncol Rep; 2013 Apr; 29(4):1429-34. PubMed ID: 23404377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming.
    Hawkins KE; Joy S; Delhove JM; Kotiadis VN; Fernandez E; Fitzpatrick LM; Whiteford JR; King PJ; Bolanos JP; Duchen MR; Waddington SN; McKay TR
    Cell Rep; 2016 Mar; 14(8):1883-91. PubMed ID: 26904936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2.
    Prigione A; Rohwer N; Hoffmann S; Mlody B; Drews K; Bukowiecki R; Blümlein K; Wanker EE; Ralser M; Cramer T; Adjaye J
    Stem Cells; 2014 Feb; 32(2):364-76. PubMed ID: 24123565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in the nuclear factor E2-related factor 2 renders pancreatic β-cells vulnerable to arsenic-induced cell damage.
    Yang B; Fu J; Zheng H; Xue P; Yarborough K; Woods CG; Hou Y; Zhang Q; Andersen ME; Pi J
    Toxicol Appl Pharmacol; 2012 Nov; 264(3):315-23. PubMed ID: 23000044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic induces reactive oxygen species-caused neuronal cell apoptosis through JNK/ERK-mediated mitochondria-dependent and GRP 78/CHOP-regulated pathways.
    Lu TH; Tseng TJ; Su CC; Tang FC; Yen CC; Liu YY; Yang CY; Wu CC; Chen KL; Hung DZ; Chen YW
    Toxicol Lett; 2014 Jan; 224(1):130-40. PubMed ID: 24157283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 mediates hypoxia-inducible HIF1α activation in kidney tubular epithelial cells.
    Potteti HR; Noone PM; Tamatam CR; Ankireddy A; Noel S; Rabb H; Reddy SP
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F464-F474. PubMed ID: 33491566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
    Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
    Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.
    Fu J; Xiong Z; Huang C; Li J; Yang W; Han Y; Paiboonrungruan C; Major MB; Chen KN; Kang X; Chen X
    J Biol Chem; 2019 Jan; 294(1):327-340. PubMed ID: 30409900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral arsenic administration to humanizedUDP-glucuronosyltransferase1 neonatal mice induces UGT1A1 through a dependence on Nrf2 and PXR.
    Yang X; Weber AA; Mennillo E; Paszek M; Wong S; Le S; Teo JYA; Chang M; Benner CW; Tukey RH; Chen S
    J Biol Chem; 2023 Mar; 299(3):102955. PubMed ID: 36720308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-cyclic phytosphingosine-1-phosphate stimulates HIF1α-dependent glycolytic reprogramming to enhance the therapeutic potential of mesenchymal stem cells.
    Lee HJ; Jung YH; Choi GE; Kim JS; Chae CW; Lim JR; Kim SY; Lee JE; Park MC; Yoon JH; Choi MJ; Kim KS; Han HJ
    Cell Death Dis; 2019 Aug; 10(8):590. PubMed ID: 31383843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
    Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
    Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.
    Li X; Han G; Li X; Kan Q; Fan Z; Li Y; Ji Y; Zhao J; Zhang M; Grigalavicius M; Berge V; Goscinski MA; Nesland JM; Suo Z
    Oncotarget; 2017 Jul; 8(28):46363-46380. PubMed ID: 28624784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role of the NRF2 transcription factor in the regulation of arsenite-mediated keratin 16 gene expression in human keratinocytes.
    Endo H; Sugioka Y; Nakagi Y; Saijo Y; Yoshida T
    Environ Health Perspect; 2008 Jul; 116(7):873-9. PubMed ID: 18629308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitofusins deficiency elicits mitochondrial metabolic reprogramming to pluripotency.
    Son MJ; Kwon Y; Son MY; Seol B; Choi HS; Ryu SW; Choi C; Cho YS
    Cell Death Differ; 2015 Dec; 22(12):1957-69. PubMed ID: 25882047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
    Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
    Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation between NRF2-mediated transcription and MDIG-dependent epigenetic modifications in arsenic-induced carcinogenesis and cancer stem cells.
    Bi Z; Zhang Q; Fu Y; Seno A; Wadgaonkar P; Qiu Y; Almutairy B; Xu L; Zhang W; Thakur C; Chen F
    Semin Cancer Biol; 2021 Nov; 76():310-318. PubMed ID: 33823236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway.
    Wang L; Yu Z; Ren S; Song J; Wang J; Du G
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2281-2292. PubMed ID: 30036603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.